Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Açın
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-0,21%
1.091,51
-2,30
-0,21%
—1.093,811.096,521.100,221.091,51——
SIXC
Communications
SIXC
Communications
SIXC
+0,22%
610,11
+1,34
+0,22%
—608,77608,77612,97608,77——
SIXE
Energy
SIXE
Energy
SIXE
-1,34%
1.237,98
-16,83
-1,34%
—1.254,811.253,011.253,871.226,33——
SIXI
Industrials
SIXI
Industrials
SIXI
-0,93%
1.744,71
-16,40
-0,93%
—1.761,111.764,271.766,881.744,71——
SIXM
Financials
SIXM
Financials
SIXM
-0,37%
640,18
-2,40
-0,37%
—642,58644,87648,48640,18——
SIXR
Staples
SIXR
Staples
SIXR
-0,18%
849,58
-1,55
-0,18%
—851,13855,66858,75845,56——
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,23%
217,48
-0,50
-0,23%
—217,98217,98218,65216,88——
SIXT
Technology
SIXT
Technology
SIXT
+1,52%
3.260,69
+48,86
+1,52%
—3.211,833.227,213.268,383.226,55——
SIXU
Utilities
SIXU
Utilities
SIXU
-0,69%
942,45
-6,53
-0,69%
—948,98948,58957,83941,97——
SIXV
Health care
SIXV
Health care
SIXV
-0,52%
1.466,80
-7,72
-0,52%
—1.474,521.479,031.481,041.466,80——
SIXY
Discretionary
SIXY
Discretionary
SIXY
+0,22%
2.397,50
+5,38
+0,22%
—2.392,122.396,952.421,222.382,32——
1ROG:BIT
Roche Holding AG Genussscheine
325,00 €
-4,89%
(-16,70) 1D
30 apr, 17:38:25 GMT+2  ·   EUR
All symbols
SymbolPriceChange% Change
Generating top insights for 1ROG...
Açın
350,75 €
High
350,75 €
Low
325,00 €
Mkt. cap
327,62 mlrd
Avg. vol.
44,00
Volume
15,00
52-wk high
414,00 €
52-wk low
258,00 €
No. of employees
113K
News stories
From sources across the web
Profile
F. Hoffmann-La Roche AG, commonly known as Roche, is a Swiss multinational holding healthcare company that operates worldwide under two divisions: Pharmaceuticals and Diagnostics. Its holding company, Roche Holding AG, has shares listed on the SIX Swiss Exchange. The company headquarters are located in Basel. Roche is the fifth-largest pharmaceutical company in the world by revenue and the leading provider of cancer treatments globally. In 2023, the company’s seat in Forbes Global 2000 was 76. The company owns the American biotechnology company Genentech, which is a wholly owned independent subsidiary, and the Japanese biotechnology company Chugai Pharmaceuticals, as well as the United States–based companies Ventana and Foundation Medicine. Roche's revenues during fiscal year 2020, were 58.32 billion Swiss francs. Descendants of the founding Hoffmann and Oeri families own slightly over half of the bearer shares with voting rights, with Swiss pharma firm Novartis owning a further third of its shares until 2021. F. Hoffmann-La Roche is a full member of the European Federation of Pharmaceutical Industries and Associations. Wikipedia
About Roche Holding AG Genussscheine
CEOThomas Schinecker
Employees113K
Founded1 okt 1896
HeadquartersBazel, Basel City, İsveçrə
SectorPharmaceutical industry
Websiteroche.com
Last report
23 apr 2026
Fiscal Period
Q1 2026
Normalized EPS / Estimate
-/ -CHF
Revenue / Estimate
14,72 mlrd/ (14,90 mlrd est.)CHF
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glanceInsights from the latest news and reports
Previous reportsAll values in CHF
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in CHF
mar 2025
iyn 2025
sen 2025
dek 2025
Revenue
15,92 mlrd
15,92 mlrd
15,75 mlrd
15,75 mlrd
Cost of goods sold
3,87 mlrd
3,87 mlrd
4,21 mlrd
4,21 mlrd
Cost of revenue
3,87 mlrd
3,87 mlrd
4,21 mlrd
4,21 mlrd
Research and development expenses
3,11 mlrd
3,11 mlrd
3,15 mlrd
3,15 mlrd
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3,29 mlrd
3,29 mlrd
3,59 mlrd
3,59 mlrd
Operating expense
6,30 mlrd
6,30 mlrd
6,82 mlrd
6,82 mlrd
Total operating expenses
10,17 mlrd
10,17 mlrd
11,03 mlrd
11,03 mlrd
Operating income
5,75 mlrd
5,75 mlrd
4,72 mlrd
4,72 mlrd
Other non operating income
4,00 mln
4,00 mln
-1,50 mln
-1,50 mln
EBT including unusual items
4,79 mlrd
4,79 mlrd
3,69 mlrd
3,69 mlrd
EBT excluding unusual items
5,46 mlrd
5,46 mlrd
4,37 mlrd
4,37 mlrd
Income tax expense
878,00 mln
878,00 mln
709,00 mln
709,00 mln
Effective tax rate
18,31%
18,31%
19,20%
19,20%
Other operating expenses
-110,50 mln
-110,50 mln
77,50 mln
77,50 mln
Net income
3,70 mlrd
3,70 mlrd
2,74 mlrd
2,74 mlrd
Net profit margin
23,27%
23,27%
17,36%
17,36%
Earnings per share
-
-
-
-
Interest and investment income
56,50 mln
56,50 mln
45,00 mln
45,00 mln
Interest expense
-304,00 mln
-304,00 mln
-289,50 mln
-289,50 mln
Net interest expenses
-247,50 mln
-247,50 mln
-244,50 mln
-244,50 mln
Depreciation and amortization charges
-
-
-
-
EBITDA
6,53 mlrd
6,53 mlrd
5,50 mlrd
5,50 mlrd
Gain or loss from assets sale
-
-
-21,50 mln
-21,50 mln
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer